Skip to main content

Wuxi Biologics Cayman

WuXi Biologics (Cayman) Inc. is a China-based contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company provides end-to-end biological drug discovery, process development, clinical trial supply, and commercial-scale manufacturing services. Its service offerings support the creation of monoclonal antibodies, antibody-drug conjugates (ADCs), and recombinant proteins for global biopharmaceutical companies. Revenue is derived from fee-for-service research contracts alongside milestone fees and commercial-scale production volume orders. WuXi Biologics maintains a leading global market position in outsourced biopharmaceutical development services. The company is headquartered in Wuxi, China, and its shares are listed on the Stock Exchange of Hong Kong.

29 of the funds FundTelligence covers report a position in Wuxi Biologics Cayman.

Legal name
Wuxi Biologics Cayman Inc
Sector
Health Care
Country
China
Funds holding it
29

Funds holding Wuxi Biologics Cayman

Showing the 8 largest of 29 funds holding it.

Loading...